Emerging Microbes & Infections

Emerging Microbes & Infections

新兴微生物和感染

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Emerging Microbes & Infections》是由Springer Nature出版社于2012年创办的英文国际期刊(ISSN: 2222-1751,E-ISSN: 2222-1751),该期刊长期致力于传染病学领域的创新研究,主要研究方向为IMMUNOLOGY-MICROBIOLOGY。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比0.9983...%),以发表传染病学领域等方向的原创性研究为核心(研究类文章占比95.59%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在227篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Emerging Microbes & Infections审稿周期约为 20 Weeks 。该刊近年未被列入国际预警名单,年发文量约227篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 227 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
INFECTIOUS DISEASES 传染病学 IMMUNOLOGY 免疫学 MICROBIOLOGY 微生物学
1区 2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学 INFECTIOUS DISEASES 传染病学 MICROBIOLOGY 微生物学
2区 2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 16 / 181

91.4%

学科:INFECTIOUS DISEASES SCIE Q1 8 / 132

94.3%

学科:MICROBIOLOGY SCIE Q1 14 / 161

91.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 7 / 181

96.41%

学科:INFECTIOUS DISEASES SCIE Q1 5 / 132

96.59%

学科:MICROBIOLOGY SCIE Q1 8 / 161

95.34%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:26.2 SJR:2.316 SNIP:1.653
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q1 3 / 157

98%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Parasitology Q1 2 / 79

98%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Infectious Diseases Q1 9 / 344

97%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Microbiology Q1 6 / 182

96%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Epidemiology Q1 6 / 148

96%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Virology Q1 4 / 80

95%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Immunology Q1 13 / 236

94%

期刊发文

  • Epidemiological characteristics and molecular features of carbapenem-resistant Enterobacter strains in China: a multicenter genomic study

    Author: Zhu, Zhichen; Xie, Xiaofang; Yu, Hua; Jia, Wei; Shan, Bin; Huang, Bin; Qu, Fen; Niu, Siqiang; Lv, Jinnan; Gao, Qizhao; Qian, Feinan; Tian, Xiangxiang; Zhai, Yaxuan; Wen, Yicheng; Yang, Chengcheng; Zhu, Jie; Tang, Yiwei; Chen, Liang; Du, Hong

    Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2148562

  • Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort

    Author: Zhu, Liguo; Mao, Naiying; Yi, Changhua; Simayi, Aidibai; Feng, Jialu; Feng, Yi; He, Min; Ding, Songning; Wang, Yin; Wang, Yan; Wei, Mingwei; Hong, Jie; Li, Chuchu; Tian, Hua; Zhou, Lu; Peng, Jiefu; Zhang, Shihan; Song, Ci; Jin, Hui; Zhu, Fengcai; Xu, Wenbo; Zhao, Jun; Bao, Changjun

    Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2146535

  • Genetic diversity and molecular epidemiology of Middle East Respiratory Syndrome Coronavirus in dromedaries in Ethiopia, 2017-2020

    Author: Zhou, Ziqi; Ali, Abraham; Walelign, Elias; Demissie, Getnet F.; El Masry, Ihab; Abayneh, Takele; Getachew, Belayneh; Krishnan, Pavithra; Ng, Daisy Y. M.; Gardner, Emma; Makonnen, Yilma; Miguel, Eve; Chevalier, Veronique; Chu, Daniel K.; So, Ray T. Y.; Von Dobschuetz, Sophie; Mamo, Gezahegne; Poon, Leo L. M.; Peiris, Malik

    Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2022.2164218

  • Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial

    Author: Zhong, Guohua; Zhuang, Chunlan; Hu, Xiaowen; Chen, Qi; Bi, Zhaofeng; Jia, Xinhua; Peng, Siying; Li, Yufei; Huang, Yue; Zhang, Qiufen; Hong, Ying; Qiao, Youlin; Su, Yingying; Pan, Huirong; Wu, Ting; Wei, Lihui; Huang, Shoujie; Zhang, Jun; Xia, Ningshao

    Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2185456

  • Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial

    Author: Zheng, Xubin; Gui, Xuwei; Yao, Lan; Ma, Jun; He, Yifan; Lou, Hai; Gu, Jin; Ying, Ruoyan; Chen, Liping; Sun, Qin; Liu, Yidian; Ho, Chih-Ming; Lee, Bai-Yu; Clemens, Daniel L.; Horwitz, Marcus A.; Ding, Xianting; Hao, Xiaohui; Yang, Hua; Sha, Wei

    Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2187247

  • Rational development of multicomponent mRNA vaccine candidates against mpox

    Author: Zhang, Rong-Rong; Wang, Zheng-Jian; Zhu, Yi-Long; Tang, Wei; Zhou, Chao; Zhao, Suo-Qun; Wu, Mei; Ming, Tao; Deng, Yong-Qiang; Chen, Qi; Jin, Ning-Yi; Ye, Qing; Li, Xiao; Qin, Cheng-Feng

    Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2192815

  • Integrated analysis reveals important differences in the gut and oropharyngeal microbiota between children with mild and severe hand, foot, and mouth disease

    Author: Zhang, Nan; Mou, Danlei; Li, Tongzeng; Chen, Zhiyun; Ma, Chunhua; Liang, Lianchun; He, Qiushui

    Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2192819

  • Identification of novel anti-ZIKV drugs from viral-infection temporal gene expression profiles

    Author: Zhang, Nailou; Tan, Zhongyuan; Wei, Jinbo; Zhang, Sai; Liu, Yan; Miao, Yuanjiu; Ding, Qingwen; Yi, Wenfu; Gan, Min; Li, Chunjie; Liu, Bin; Wang, Hanzhong; Zheng, Zhenhua

    Journal: EMERGING MICROBES & INFECTIONS. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1080/22221751.2023.2174777